ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹522 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr | ₹287 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹531 Cr |
| Mar2023 | ₹129 Cr |
| Mar2022 | ₹144 Cr |
| Mar2021 | ₹287 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -1.70 | |
| Mar2024 | ₹531 Cr | 311.08 | |
| Mar2023 | ₹129 Cr | -10.07 | |
| Mar2022 | ₹144 Cr | -49.96 | |
| Mar2021 | ₹287 Cr | - | |
Compare Net Current Assets of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,835.1 Cr | 5.4% | 12.1% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 5.4% |
12.1% |
-32.1% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses